Table 3.
Reference Summary of HPV DNA Detection in Cervical Adenocarcinomas and Related Tumors
| Diagnosis | n | HPV DNA positive (%) | HPV 16:18 (%:%) | References |
|---|---|---|---|---|
| Adenocarcinomas | ||||
| Adenocarcinoma in situ | 23 | 100 | 43:26 | Pirog et al. (current study) |
| 21 | 76 | 37:63 | Anciaux et al. 1997 | |
| 37 | 66 | 35:65 | Duggan et al. 1994 | |
| 9 | 78 | 29:71 | Stoler et al. 1994 | |
| 30 | 70 | 48:52 | Leary et al. 1991 | |
| Mucinous Adenocarcinomas | ||||
| Endocervical-type adenocarcinoma | 55 | 91 | 44:42 | Pirog et al. (current study) |
| 12 | 92 | not available | Ferguson et al. 1998 | |
| 88 | 97 | 50:50 | Tenti et al. 1996 | |
| 47 | 64 | 50:36 | Duggan et al. 1995 | |
| 16 | 81 | 38:62 | Stoler et al. 1994 | |
| 15 | 80 | 46:54 | Milde-Langosch et al. 1993 | |
| Intestinal-type adenocarcinoma | 6 | 83 | 0:20 | Pirog et al. (current study) |
| 7 | 71 | 43:57 | Tenti et al. 1996 | |
| 1 | 100 | 0:100 | Duggan et al. 1995 | |
| Endometrioid-type adenocarcinoma | 4 | 100 | 50:50 | Pirog et al. (current study) |
| 9 | 44 | not available | Ferguson et al. 1998 | |
| 33 | 58 | 57:43 | Tenti et al. 1996 | |
| 6 | 67 | 50:50 | Duggan et al. 1995 | |
| 7 | 86 | 50:50 | Stoler et al. 1994 | |
| 5 | 60 | 100:0 | Milde-Langosch et al. 1993 | |
| Minimal deviation adenocarcinoma | 2 | 0 | 0 | Pirog et al. (current study) |
| 6 | 0 | 0 | Toki et al. 1999 | |
| 3 | 0 | 0 | Ferguson et al. 1998 | |
| Nonmucinous Adenocarcinomas | ||||
| Clear cell adenocarcinoma | 4 | 0 | 0 | Pirog et al. (current study) |
| 10 | 70 | 25:75 | Tenti et al. 1996 | |
| 1 | 100 | 100:0 | Duggan et al. 1995 | |
| 14 | 21 | HPV 31 only | Waggoner et al. 1994 | |
| 4 | 50 | 0:100 | Stoler et al. 1994 | |
| 1 | 0 | 0 | Milde-Langosch et al. 1993 | |
| Serous adenocarcinoma | 1 | 0 | 0 | Pirog et al. (current study) |
| 2 | 100 | 0:100 | Duggan et al. 1995 | |
| 1 | 0 | 0 | Milde-Langosch et al. 1993 | |
| Carcinomas with adenosquamous differentiation | ||||
| Adenosquamous carcinoma | 6 | 100 | 33:33 | Pirog et al. (current study) |
| 19 | 100 | 74:16 | van Muyden et al. 1999 | |
| 8 | 50 | 25:75 | Anciaux et al. 1997 | |
| 17 | 76 | 46:31 | Duggan et al. 1995 | |
| 21 | 91 | 52:48 | Yamakawa et al. 1994 | |
| 13 | 77 | 50:50 | Stoler et al. 1994 | |
| Adenoid basal carcinoma | 2 | 100 | 100:0 | Pirog et al. (current study) |
| 9 | 67 | 66:0 | Grayson et al. 1997 | |
| Adenoid cystic carcinoma | 11 | 73 | 85:0 | Grayson et al. 1996 |
| 1 | 0 | 0 | Stoler et al. 1994 | |
| Glassy cell carcinoma | 1 | 100 | 0:100 | Pirog et al. (current study) |
| 18 | 28 | 20:80 | Kenny et al. 1992 | |
| 3 | 66 | 0:100 | Stoler et al. 1994 | |
| Clear cell adenosquamous carcinoma | 11 | 100 | 0:100 | Fujiwara et al. 1995 |